Is Left Ventricular Hypertrophy a Valid Therapeutic Target?

被引：0
|
作者：
Jeremy Earl Brooks
Elsayed Z. Soliman
Bharathi Upadhya
机构：
[1] Wake Forest School of Medicine,Cardiovascular Medicine Section, Department of Internal Medicine
[2] Wake Forest School of Medicine,Epidemiological Cardiology Research Center, Department of Epidemiology and Prevention
来源：
Current Hypertension Reports | 2019年 / 21卷
关键词：
Systolic blood pressure; Left ventricular hypertrophy; Regression; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Is Left Ventricular Hypertrophy a Valid Therapeutic Target?
    Brooks, Jeremy Earl
    Soliman, Elsayed Z.
    Upadhya, Bharathi
    CURRENT HYPERTENSION REPORTS, 2019, 21 (06)
  • [2] Therapeutic options in minimizing left ventricular hypertrophy
    Devereux, RB
    AMERICAN HEART JOURNAL, 2000, 139 (01) : S9 - S14
  • [3] Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention
    Mohan, Mohapradeep
    Dihoum, Adel
    Mordi, Ify R.
    Choy, Anna-Maria
    Rena, Graham
    Lang, Chim C.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [4] Left Ventricular Hypertrophy as a Target of Treatment in Patients With Hypertension
    Goda, Akiko
    Masuyama, Tohru
    CIRCULATION JOURNAL, 2014, 78 (11) : 2633 - 2634
  • [5] Therapeutic effects of irbesartan in left ventricular hypertrophy.
    Feraco, E
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 115A - 115A
  • [6] THERAPEUTIC ADVANCES IN THE TREATMENT OF LEFT-VENTRICULAR HYPERTROPHY
    NATSUME, T
    EUROPEAN HEART JOURNAL, 1993, 14 : 33 - 37
  • [7] Comparison of therapeutic studies on regression of left ventricular hypertrophy
    Schmieder, RE
    Schlaich, MP
    HYPERTENSION AND THE HEART, 1997, 432 : 191 - 198
  • [8] LEFT-VENTRICULAR HYPERTROPHY - A CRUCIAL TARGET FOR ANTIHYPERTENSIVE THERAPY
    MESSERLI, FH
    POSTGRADUATE MEDICINE, 1990, 88 (01) : 127 - +
  • [9] Regression of left ventricular hypertrophy by inhibition of mammalian target of rapamycin
    Gao, XM
    Wong, G
    Wang, BH
    Moore, XL
    Su, YD
    Xu, Q
    Du, XJ
    CIRCULATION RESEARCH, 2005, 97 (02) : E31 - E31
  • [10] Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?
    Sheridan, DJ
    Kingsbury, MP
    Flores, NA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 47 (02) : 125 - 130
12345